Biotricity (BTCY) Proxy Filing summary

Executive summary

• Annual meeting scheduled for August 15, 2024, with voting on key proposals including director elections, auditor ratification, equity issuance, and potential adjournment.

Voting matters and shareholder proposals

• Election of four directors to serve until the next annual meeting and until successors are qualified.

• Ratification of SRCO Professional Corporation as independent auditor for the year ending March 31, 2025.

• Approval sought for issuance of up to $6,600,000 in common stock upon conversion of Series B Convertible Preferred Stock, bypassing Nasdaq's 20% Rule.

• Proposal to adjourn the meeting if additional proxy solicitation is needed for approval of proposals.

Board of directors and corporate governance

• Proxy solicited on behalf of the board, with John Ayanoglou appointed as proxy agent.

• Board recommends voting in favor of all proposals presented.